Yushmanova I - Search Results

1

SYNCHRONIZE: Real-World Retrospective Safety Analysis of Patients Treated with OnabotulinumtoxinA for More than One Therapeutic Indication.

Forde G, Brucker BM, Becker Ifantides K, Patel AT, Mayadev A, Brown T, Ayyoub Z, Martinez K, Singh R, Nelson M, Battucci S, Yushmanova I, Ukah A, Rhyne C. Forde G, et al. Among authors: yushmanova i. Toxins (Basel). 2024 Sep 29;16(10):420. doi: 10.3390/toxins16100420. Toxins (Basel). 2024. PMID: 39453196 Free PMC article.

2

Efficacy and safety of onabotulinumtoxinA for the treatment of overactive bladder in men and women: A pooled analysis.

Nitti VW, Kohan A, McCammon K, Jenkins B, Ifantides KB, Yushmanova I, Chapple C. Nitti VW, et al. Among authors: yushmanova i. Neurourol Urodyn. 2024 Nov;43(8):1765-1775. doi: 10.1002/nau.25538. Epub 2024 Jul 8. Neurourol Urodyn. 2024. PMID: 38973548 Free article.

3

Safety and tolerability of onabotulinumtoxinA in the treatment of upper facial lines from global registration studies in 5298 participants: A meta-analysis.

Brin MF, De Boulle K, Liew S, Carruthers A, Carruthers J, Rivkin A, Wu Y, Kawashima M, Yushmanova I, Boodhoo TI, Lee E. Brin MF, et al. Among authors: yushmanova i. JAAD Int. 2023 Sep 9;14:4-18. doi: 10.1016/j.jdin.2023.07.021. eCollection 2024 Mar. JAAD Int. 2023. PMID: 38035126 Free PMC article.

4

Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX^®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis.

Jankovic J, Carruthers J, Naumann M, Ogilvie P, Boodhoo T, Attar M, Gupta S, Singh R, Soliman J, Yushmanova I, Brin MF, Shen J. Jankovic J, et al. Among authors: yushmanova i. Toxins (Basel). 2023 May 17;15(5):342. doi: 10.3390/toxins15050342. Toxins (Basel). 2023. PMID: 37235376 Free PMC article.

5

Pregnancy Outcomes in Patients Exposed to OnabotulinumtoxinA Treatment: A Cumulative 29-Year Safety Update.

Brin MF, Kirby RS, Slavotinek A, Adams AM, Parker L, Ukah A, Radulian L, Elmore MRP, Yedigarova L, Yushmanova I. Brin MF, et al. Among authors: yushmanova i. Neurology. 2023 Jul 11;101(2):e103-e113. doi: 10.1212/WNL.0000000000207375. Epub 2023 May 3. Neurology. 2023. PMID: 37137724 Free PMC article.

6

Reply by Authors.

Franco I, Hoebeke PB, Dobremez E, Titanji W, Geib T, Jenkins B, Yushmanova I, Austin PF. Franco I, et al. Among authors: yushmanova i. J Urol. 2023 Apr;209(4):783-784. doi: 10.1097/JU.0000000000003157.03. Epub 2023 Apr 1. J Urol. 2023. PMID: 36891836 No abstract available.

7

Long-term Safety and Tolerability of Repeated Treatments With OnabotulinumtoxinA in Children With Neurogenic Detrusor Overactivity.

Franco I, Hoebeke PB, Dobremez E, Titanji W, Geib T, Jenkins B, Yushmanova I, Austin PF. Franco I, et al. Among authors: yushmanova i. J Urol. 2023 Apr;209(4):774-784. doi: 10.1097/JU.0000000000003157. Epub 2023 Jan 19. J Urol. 2023. PMID: 36655470 Clinical Trial.

8

Safety and Stability of Pulmonary Function in Patients with Decreased Respiratory Function Treated for Spasticity with OnabotulinumtoxinA.

Ayyoub Z, Brashear A, Banach M, Schoene R, Stringer W, Boodhoo T, Yushmanova I, Dimitrova R, Brin MF. Ayyoub Z, et al. Among authors: yushmanova i. Toxins (Basel). 2020 Oct 19;12(10):661. doi: 10.3390/toxins12100661. Toxins (Basel). 2020. PMID: 33086749 Free PMC article. Clinical Trial.

9

Safety of OnabotulinumtoxinA with Concomitant Antithrombotic Therapy in Patients with Muscle Spasticity: A Retrospective Pooled Analysis of Randomized Double-Blind Studies.

Dimitrova R, James L, Liu C, Orejudos A, Yushmanova I, Brin MF. Dimitrova R, et al. Among authors: yushmanova i. CNS Drugs. 2020 Apr;34(4):433-445. doi: 10.1007/s40263-020-00709-5. CNS Drugs. 2020. PMID: 32170665 Free PMC article.

10

Real-World Safety And Effectiveness Of OnabotulinumtoxinA Treatment Of Crow's Feet Lines And Glabellar Lines: Results Of A Korean Postmarketing Surveillance Study.

Yi DJ, Hwang S, Son J, Yushmanova I, Anson Spenta K, St Rose S. Yi DJ, et al. Among authors: yushmanova i. Clin Cosmet Investig Dermatol. 2019 Nov 19;12:851-856. doi: 10.2147/CCID.S227493. eCollection 2019. Clin Cosmet Investig Dermatol. 2019. PMID: 31819582 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Search Page

Filters